Author:
Gilbert Jill,Carducci Michael A.,Baker Sharyn D.,Dees Elizabeth C.,Donehower Ross
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Reference5 articles.
1. Grant S (1990) Biochemical modulation of cytosine arabinoside. Pharmac Ther 48:29–44
2. Fadl TL, Hasegawa T, Youssef AF, Farag HH, Omar FA, Kawaguchi T (1995) Synthesis and investigation of N4 –substituted cytarabine derivatives as prodrugs. Pharmazie 50:382–387
3. Noble S, Goa K (1997) Gemcitabine: A review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer. Drugs 54:447–472
4. Ruiz, van Haperen VW, Veerman G, Vermorken JB, Peters GJ (1993) 2′,2-difluoro-deoxycytidine (gemcitabine)incorporation into RNA and DNA of tumor cell lines. Biochem Pharmacol 46:762–766
5. Hanaoka K, Suzuki M, Kobayashi T, Tanzawa F, Tanaka K, Shibayama T, Miura S, Ikelda T, Iwabuchi H, Nakagawa A, Mitsuhashi Y, Hisaoka M, Kaneko M, Tomida A, Wataya Y, Nomura T, Sasaki T, Matsuda A, Tsuruo T, Kurakata S (1999) Antitumor activity and novel DNA self-strand breaking mechanism of CNDAC (1(2-c-cyano-2-deoxy-β-D-arabino-pentofuranosyl) cytosine) and its N4 –Palmitoyl Derivative (CS-682). Int J Cancer 82:226–236
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献